Category: CLSI

CLSI

CLSI GP41-A6

Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard-Sixth Edition, GP41A6Estandard by Clinical and Laboratory Standards Institute, 11/01/2007

CLSI EP25-A

Evaluation of Stability of In Vitro Diagnostic Reagents; Approved Guideline, EP25Astandard by Clinical and Laboratory Standards Institute, 09/01/2009

CLSI M11-A8

Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard - Eighth Edition, M11A8Estandard by Clinical and Laboratory Standards Institute, 02/01/2012

CLSI C56-A

Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis; Approved Guideline, C56AEstandard by Clinical and Laboratory Standards Institute, 07/01/2012

CLSI I/LA29-A

Detection of HLA-Specific Alloantibody by Flow Cytometry and Solid Phase Assays, Proposed Guideline, ILA29AEstandard by Clinical and Laboratory Standards Institute, 01/01/2008

CLSI H42-A2 (R2018)

Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline, Second Edition, H42-A2standard by Clinical and Laboratory Standards Institute, 05/01/2007

CLSI GP47 (R2019)

Management of Critical- and Significant-Risk Results, 1st Edition, GP47Ed1E, GP47ESEd1Estandard by Clinical and Laboratory Standards Institute, 12/01/2015

CLSI C40-A2

Analytical Procedures for the Determination of Lead in Blood and Urine; Approved Guideline, C40A2Estandard by Clinical and Laboratory Standards Institute, 10/01/2013

CLSI M44-A2

Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, 3rd Edition, M44Ed3Estandard by Clinical and Laboratory Standards Institute, 12/10/2018

CLSI EP23-A (R2018)

Laboratory Quality Control Based on Risk Management; Approved Guideline, EP23AEstandard by Clinical and Laboratory Standards Institute, 10/01/2011